Your browser doesn't support javascript.
Hofbauer Cells and COVID-19 in Pregnancy.
Schwartz, David A; Baldewijns, Marcella; Benachi, Alexandra; Bugatti, Mattia; Bulfamante, Gaetano; Cheng, Ke; Collins, Rebecca R J; Debelenko, Larisa; De Luca, Danièle; Facchetti, Fabio; Fitzgerald, Brendan; Levitan, Daniel; Linn, Rebecca L; Marcelis, Lukas; Morotti, Denise; Morotti, Raffaella; Patanè, Luisa; Prevot, Sophie; Pulinx, Bianca; Saad, Ali G; Schoenmakers, Sam; Strybol, David; Thomas, Kristen; Tosi, Delfina; Toto, Valentina; van der Meeren, Lotte E; Verdijk, Robert M; Vivanti, Alexandre J; Zaigham, Mehreen.
  • Schwartz DA; From the Department of Pathology, Medical College of Georgia, Augusta (Schwartz).
  • Baldewijns M; Department of Pathology, University Hospitals Leuven, Leuven, Belgium (Baldewijns).
  • Benachi A; Division of Obstetrics and Gynecology, Antoine Béclère Hospital, Paris Saclay University Hospitals, Clamart, France (Benachi).
  • Bugatti M; Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy (Bugatti).
  • Bulfamante G; Hospital Complex for Pathological Anatomy and Medical Genetics, ASST Santi Paolo e Carlo, Milan, Italy Department of Health Sciences, University of Milan, Milan, Italy (Bulfamante).
  • Cheng K; HistoWiz, Inc., Brooklyn, New York (Cheng).
  • Collins RRJ; Department of Pathology, University of Texas Southwestern Medical Center, Dallas (Collins).
  • Debelenko L; Department of Pediatric and Perinatal Pathology, Columbia University Medical Center, New York, New York (Debelenko).
  • De Luca D; Neonatology Division of Pediatrics, Transportation and Neonatal Critical Care APHP, Paris Saclay University Hospitals, Medical Center "A.Béclère" & Physiopathology and Therapeutic Innovation Unit, Paris-Saclay University, Paris, France (De Luca).
  • Facchetti F; Pathology Unit, Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy (Facchetti).
  • Fitzgerald B; Department of Pathology, Cork University Hospital, Wilton, Cork, Ireland (Fitzgerald).
  • Levitan D; Department of Pathology, SUNY Downstate Medical Center, Brooklyn, New York (Levitan).
  • Linn RL; Department of Pathology & Lab Medicine, Perelman School of Medicine at the University of Pennsylvania & Children's Hospital of Philadelphia, Philadelphia (Linn).
  • Marcelis L; Department of Pathology, UZ Leuven, Leuven, Belgium (Marcelis).
  • Morotti D; Pathology Unit and Medical Genetics Laboratory, Papa Giovanni XXIII Hospital, Bergamo, Italy (D Morotti).
  • Morotti R; Department of Pathology and Pediatrics, Autopsy Service, Yale University School of Medicine, New Haven, Connecticut (R Morotti).
  • Patanè L; Department of Obstetrics and Gynecology, Papa Giovanni XXIII Hospital, Bergamo, Italy (Patanè).
  • Prevot S; Division of Pathology, Bicêtre Hospital, Paris Saclay University Hospitals, APHP, Le Kremlin-Bicêtre, France (Prevot).
  • Pulinx B; Department of Clinical Biology, Sint-Trudo Hospital, Sint-Truiden, Belgium (Pulinx).
  • Saad AG; Department of Pathology, University of Miami Miller School of Medicine/Jackson Health System/Holtz Children's Hospital, Miami, Florida (Saad).
  • Schoenmakers S; Department of Obstetrics and Gynaecology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands (Schoenmakers).
  • Strybol D; Department of Pathology, Sint-Trudo Hospital, Sint-Truiden, Belgium (Strybol).
  • Thomas K; Department of Pathology, NYU Langone Health, Main Campus & Bellevue Hospital Center, New York University School of Medicine, New York (Thomas).
  • Tosi D; Department of Health Sciences, University of Milan, Milan, Italy (Tosi).
  • Toto V; Hospital Complex for Pathological Anatomy and Medical Genetics, ASST Santi Paolo e Carlo, Milan, Italy (Toto).
  • van der Meeren LE; Department of Pathology, Leiden University Medical Center (van der Meeren).
  • Verdijk RM; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands (van der Meeren).
  • Vivanti AJ; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands (Verdijk).
  • Zaigham M; Department of Obstetrics and Gynecology, Antoine Beclere Hospital, APHP, Université Paris Saclay, Clamart, France (Vivanti).
Arch Pathol Lab Med ; 145(11): 1328-1340, 2021 11 01.
Article in English | MEDLINE | ID: covidwho-1485410
ABSTRACT
CONTEXT.­ SARS-CoV-2 can undergo maternal-fetal transmission, heightening interest in the placental pathology findings from this infection. Transplacental SARS-CoV-2 transmission is typically accompanied by chronic histiocytic intervillositis together with necrosis and positivity of syncytiotrophoblast for SARS-CoV-2. Hofbauer cells are placental macrophages that have been involved in viral diseases, including HIV and Zika virus, but their involvement in SARS-CoV-2 is unknown. OBJECTIVE.­ To determine whether SARS-CoV-2 can extend beyond the syncytiotrophoblast to enter Hofbauer cells, endothelium, and other villous stromal cells in infected placentas of liveborn and stillborn infants. DESIGN.­ Case-based retrospective analysis by 29 perinatal and molecular pathology specialists of placental findings from a preselected cohort of 22 SARS-CoV-2-infected placentas delivered to pregnant women testing positive for SARS-CoV-2 from 7 countries. Molecular pathology methods were used to investigate viral involvement of Hofbauer cells, villous capillary endothelium, syncytiotrophoblast, and other fetal-derived cells. RESULTS.­ Chronic histiocytic intervillositis and trophoblast necrosis were present in all 22 placentas (100%). SARS-CoV-2 was identified in Hofbauer cells from 4 of 22 placentas (18.2%). Villous capillary endothelial staining was positive in 2 of 22 cases (9.1%), both of which also had viral positivity in Hofbauer cells. Syncytiotrophoblast staining occurred in 21 of 22 placentas (95.5%). Hofbauer cell hyperplasia was present in 3 of 22 placentas (13.6%). In the 7 cases having documented transplacental infection of the fetus, 2 (28.6%) occurred in placentas with Hofbauer cell staining positive for SARS-CoV-2. CONCLUSIONS.­ SARS-CoV-2 can extend beyond the trophoblast into the villous stroma, involving Hofbauer cells and capillary endothelial cells, in a small number of infected placentas. Most cases of SARS-CoV-2 transplacental fetal infection occur without Hofbauer cell involvement.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Placenta / Pregnancy Complications, Infectious / Infectious Disease Transmission, Vertical / SARS-CoV-2 / COVID-19 / Macrophages Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Infant, Newborn / Pregnancy Language: English Journal: Arch Pathol Lab Med Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Placenta / Pregnancy Complications, Infectious / Infectious Disease Transmission, Vertical / SARS-CoV-2 / COVID-19 / Macrophages Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Infant, Newborn / Pregnancy Language: English Journal: Arch Pathol Lab Med Year: 2021 Document Type: Article